Show items per page
Elements: 25
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis Shubber, Zara; Calmy, Alexandra; Andrieux-Meyer, Isabelle; Vitoria, Marco; ... Ford, Nathan 2013
add to browser selection
Adverse events of raltegravir and dolutegravir Elzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Cavassini, Matthias; ... Battegay, Manuel 2017
add to browser selection
Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study Yang, Wan-Lin; Kouyos, Roger D; Scherrer, Alexandra U; Böni, Jürg; ... Günthard, Huldrych F 2015
add to browser selection
Benefits and risks of rapid initiation of antiretroviral therapy Ford, Nathan; Migone, Chantal; Calmy, Alexandra; Kerschberger, Bernhard; ... Shubber, Zara 2018
add to browser selection
Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy Ananworanich, Jintanat; Nuesch, Reto; Côté, Hélène C. F.; Kerr, Stephen J.; ... Hirschel, Bernard 2008
add to browser selection
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study Franceschi, S.; Lise, M.; Clifford, G. M.; Rickenbach, M.; ... Keiser, Olivia 2010
add to browser selection
Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study Hasse, Barbara; Walker, A Sarah; Fehr, Jan; Furrer, Hansjakob; ... Ledergerber, Bruno 2014
add to browser selection
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis Kanters, Steve; Socias, Maria Eugenia; Paton, Nicholas I; Vitoria, Marco; ... Mills, Edward J 2017
add to browser selection
Expert reviews: who are they for? Ford, Nathan; Calmy, Alexandra 2012
add to browser selection
Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy Calmy, Alexandra; Hirschel, Bernard; Hans, Didier; Karsegard, V. L.; Meier, C. A. 2003
add to browser selection
HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy Oehler-Jänne, Christoph; Huguet, Florence; Provencher, Sawyna; Seifert, Burkhardt; ... Ciernik, I Frank 2008
add to browser selection
Human papillomavirus antibody response following HAART initiation among MSM. Combes, Jean-Damien; Clifford, Gary M; Egger, Matthias; Cavassini, Matthias; ... Scherrer, Alexandra U 2017
add to browser selection
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? Calmy, Alexandra 2018
add to browser selection
Initial treatment for HIV infection--an embarrassment of riches Hirschel, Bernard; Calmy, Alexandra 2008
add to browser selection
Microstructural alterations of trabecular and cortical bone in long-term HIV-infected elderly men on successful antiretroviral therapy Biver, Emmanuel; Calmy, Alexandra; Delhumeau-Cartier, Cécile; Durosier, Claire; ... Rizzoli, René 2014
add to browser selection
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial Bonnet, Maryline; Bhatt, Nilesh; Baudin, Elisabeth; Silva, Carlota; ... Calmy, Alexandra 2013
add to browser selection
No change in calculated creatinine clearance after tenofovir initiation among Thai patients Gayet-Ageron, Angèle; Ananworanich, Jintanat; Jupimai, Thidarat; Chetchotisakd, Ploenchan; ... Hirschel, Bernard 2007
add to browser selection
Pharmacokinetics of the Protein Microbicide 5P12-RANTES in Sheep following Single-Dose Vaginal Gel Administration McBride, John W; Dias, Nicola; Cameron, David; Offord, Robin Ewart; ... Malcolm, R Karl 2017
add to browser selection
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir Young, Jim; Schäfer, Juliane; Fux, Christoph A; Furrer, Hansjakob; ... Bucher, Heiner C 2012
add to browser selection
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study Sculier, Delphine; Gayet-Ageron, Angèle; Battegay, Manuel; Cavassini, Matthias; ... Calmy, Alexandra 2017
add to browser selection
Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis Ford, Nathan; Mofenson, Lynne; Shubber, Zara; Calmy, Alexandra; ... Renaud, Françoise 2014
add to browser selection
Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy Ramjan, Rubeena; Calmy, Alexandra; Vitoria, Marco; Mills, Edward J; ... Ford, Nathan 2014
add to browser selection
The future role of CD4 cell count for monitoring antiretroviral therapy Ford, Nathan; Meintjes, Graeme; Pozniak, Anton; Bygrave, Helen; ... Siberry, George K 2015
add to browser selection
The Monark trial: where now for boosted protease inhibitor monotherapy? Hill, Andrew; Hirschel, Bernard; Katlama, Christine 2008
add to browser selection
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011 Jordan, M R; Bennett, D E; Wainberg, M A; Havlir, D; ... Bertagnolio, S 2012